MNDY — AI Stock Forecast & Price Targets
Published 9/1/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live MNDY price forecast →
MNDY has rallied from the low-$80s to $101 on strong Q2 execution, AI ARR doubling sequentially, and a 20% RIF that lifted the margin guide to ~15%, leaving the stock at ~15x forward P/E, 0.69 PEG, and ~21% FCF margin with ~$820M net cash. However, price is now +20% above the 50-day, +10% above the 20-day, RSI 64, and the AI 1h/1d forecasts point sharply lower into a risk-off tape — so the setup argues for holding/trimming strength rather than chasing, with re-accumulation zone $86-92 into the Nov 9 print.
Do not chase at $101. Price is extended (+10% above 20-day, +20% above 50-day) into a risk-off tape (breadth deteriorating, defensive leadership) with the AI 1d forecast projecting a sharp mean-reversion. If long from lower, trim 20-30% into $102-105 resistance. For new entries, wait for a pullback to $92-95 (20-day / breakout retest); scale a second tranche at $86-88 (50-day / prior consolidation). Hard invalidation for the tactical long is a decisive close below $84 on volume, which would break the higher-low structure.
The core 1-6 month thesis is that MNDY re-rates modestly higher as margin expansion (~15% op margin), buyback per-share accretion, and AI ARR traction offset the Q3 growth deceleration to 16-17%. Base case $108-115 (16-17x forward EPS ~$6.68, in line with sell-side target $106.45), bull case $130-140 requires a Q3 beat-and-raise on Nov 9 with AI ARR at the high end of the 15-20% net-new-bookings target. Bear case $78-82 on an in-line print interpreted as a structural growth ceiling. Expected return range from $101: -20% to +30% asymmetry, skewed positive if the Q3 print holds. Change my mind: Q3 revenue misses the guide, or op margin fails to expand toward the 15% target.
1-3 year terminal thesis: MNDY becomes a durable ~$2B+ revenue platform with 20%+ FCF margins, multi-product cross-sell (CRM, dev, service) driving ARPU expansion, and AI credits materially lifting net-new bookings. If the company can hold high-teens growth with 20% op margins and continue retiring shares, EPS trajectory to $10+ by 2028 supports a $180-220 fair value at 20x. Biggest structural risk: Microsoft's Loop/Planner + Copilot bundle erodes MNDY's horizontal work-management wedge, forcing pricing concessions and NDR compression — this is the scenario where the stock stays range-bound $70-110 for years despite good fundamentals.
The franchise quality remains best-in-class: 88.7% gross margin, TTM revenue $1.37B (+24% YoY), and a return to positive GAAP operating income ($19.8M in Q1 2026 vs. -$11.6M in Q2 2025). FCF is strong and improving — Q1 2026 FCF of $102M annualizes toward a ~$285M TTM run-rate (~21% FCF margin), and operating cash flow of $315M TTM easily covers modest capex (~$22M TTM). The balance sheet held $997M cash against $178M debt at Q1 2026, still net cash of ~$820M even after the large buyback drew cash from $1.59B a year ago — capital allocation has been per-share accretive (float now ~32M with 42.3M shares outstanding implying meaningful insider/restricted holdings). What's working: margin expansion post-RIF (op margin guide raised from ~13% to ~15%), AI Work Platform ARR doubling sequentially, and $100K+ ARR enterprise cohort strength. What's under pressure: Q3 guide implies deceleration to 16-17% growth (vs. 22% in Q1), Q4 2025 net margin of 23% was inflated by non-recurring items, and GAAP operating margin (~5.6% in Q1) still leaves little cushion. At 15.1x forward P/E, 0.69 PEG, 13.5x P/FCF and ~$3.4B EV, the valuation is inexpensive for a 88% gross margin SaaS compounder if growth stabilizes above the mid-teens.
The daily chart shows a clean base breakout: MNDY bottomed near $57 in early summer, reclaimed $75 support, and has trended higher to $101 — now +10.2% above 20-day, +20.2% above 50-day, +5.1% above 200-day, RSI 64.5 (approaching but not at overbought). Weekly still shows a multi-year downtrend from $380 to a $60 base, so we're in early-stage recovery within a broken longer-term structure — resistance is stacked at $105, $117 (year-ago pivot), and $135-140. Immediate resistance is the recent $102 swing high visible on the 1h chart. The Kronos 1h and 1d forecasts both project sharp downside toward $79-80 (base) with wide bands, but the model's realized directional accuracy at 1d (61%) and 1wk (50%) is BELOW naive baseline in this regime — so I discount the specific magnitude while acknowledging the pullback risk it flags. The 1wk forecast points up to $210, which is not credible on any near-term horizon and confirms the model is fighting itself across timeframes. Net: extended short-term, healthy structure, first supports at $95 (breakout retest), $90 (20-day area), then $84-86 base.
Signal: (1) The seats-plus-credits AI monetization thesis is being externally validated — the Seeking Alpha piece from 8/26 flags AI ARR doubling sequentially as a structural pricing-model shift, consistent with management commentary. (2) The stock crossed above both its 20-day (8/19) and 200-day (8/28) SMAs, confirming a technical regime change from the sub-$80 base. (3) Zacks/Wall Street ABR skews toward buy (Recom 1.84, target $106.45 — essentially at spot), suggesting limited near-term sell-side re-rating juice without a Q3 beat-and-raise. (4) Fundamental-change signals show short float has whipsawed 20.2% → 13.8% → 17.0% over 45 days, indicating active short repositioning around the AI narrative. Noise: broad market news (gold, European gas, Kala Bio) is unrelated. The Simply Wall St piece notes the five-year -78.6% drawdown, which is why the re-rating opportunity exists — the market has already priced in significant pessimism.
- AI Work Platform ARR doubled sequentially in Q2 2026; management targets 15-20% of net-new bookings by year-end via seats-plus-credits pricing
- Non-GAAP operating margin guide raised from ~13% to ~15% post-20% RIF, adding ~$50M+ annualized operating income
- $870M buyback authorization retiring ~20% of float — materially per-share accretive with EPS TTM already +206% YoY
- Multi-product expansion (monday CRM, dev, service) enabling cross-sell into existing $100K+ ARR enterprise cohort where NDR is strongest
- Enterprise cohort growth (>$100K ARR) anchoring topline as SMB softens; Q1 2026 revenue +21.9% YoY to $351M sustains high-teens/low-20s trajectory
- Goldman Sachs disclosed 6.6% beneficial stake (8/10/2026 filing) — institutional accumulation validating the AI-pivot re-rating
- Q3 (Nov 9) guide implies deceleration to 16-17% YoY growth — if structural rather than transient, forward multiple compresses back below 13x
- Short float re-expanded to 17% with 3.5 days-to-cover; in-line-guide reactions can trigger sharp -10-15% gap-downs
- Stock is +20% above 50-day and RSI 64.5 into a risk-off SPY regime (breadth 52% deteriorating) — mean-reversion risk is elevated
- Microsoft Copilot + Loop/Planner bundle is a persistent competitive overhang on horizontal work-management pricing power
- Execution risk on the 20% RIF during an AI re-architecture — product roadmap slippage or key departures would break the pivot narrative
- Israeli domicile geopolitical tail risk; institutional ownership softened 82.4% → 78.4% in mid-August (L1 bearish signal)
- Sell-side price target ($106.45) sits only ~5% above spot, capping near-term re-rating without a Q3 beat-and-raise catalyst
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord